Polaris portfolio

Polaris has 20 portfolio companies on record at Recent Funding, with 4 investments in the last 12 months.

X: @PolarisVC.

Type: Investor.

Portfolio on Recent Funding: 20.

Deals, last 12 months: 4.

Rounds led: 5 of 24.

Capital in their rounds: $1.59B.

Latest deal: Soufflé Therapeutics · Oct 13, 2026.

About this page

It led 5 of the 24 rounds it joined. Its most recent investment on record is Soufflé Therapeutics's $135M Series B+ round in October 2026, alongside TAS Partners, Leaps by Bayer, Vida Ventures and 6 others. By category, its portfolio leans toward Health and bio (12) and Fintech (4). It has co-invested with Temasek, AbbVie and Invus, most often Temasek (4 rounds).

Funds raised

Fund	Fund #	Size	Announced
PPolaris Partners	X	$355M	Apr 24, 2023 The Business Journals

What Polaris invests in

Health and bio · 12 · 60%
Fintech · 4 · 20%
Commerce and retail · 2 · 10%
Stablecoins · 2 · 10%
Lending and credit · 2 · 10%
Robotics and hardware · 2 · 10%
Prediction markets · 1 · 5%
Crypto payments · 1 · 5%

Polaris recent investments

Company	Round	Date	Alongside
SSoufflé Therapeutics	Series B+ · $135M	Oct 13, 2026	TAS Partners, Leaps by Bayer, Vida Ventures +6
TTropic Biosciences	Series B+ · $105M	Mar 12, 2026	Forbion Capital Partners (lead), IQ Capital, Aliment Capital +6
KKash	Pre-seed · $2M	Feb 24, 2026	The Spartan Group, Kosmos Ventures, Moonrock Capital +6
BBirch Hill	Pre-seed	Feb 11, 2026	FalconX, Naman Kapasi, David Miller +10
SSovato	Series B+ · $41M	Nov 4, 2025	Beringea (lead), Laerdal Million Lives Fund, Intuitive Ventures +3
SSoufflé Therapeutics	Series A · $200M	Oct 13, 2025	AbbVie, ARCH Venture Partners, Leaps by Bayer +4
CCohere Health	Series B+ · $90M	May 14, 2025	Flare Capital Partners, Longitude Capital, Define Ventures +2
VVico Therapeutics	Series B+ · $71M	Jun 24, 2024	EQT Life Sciences, Ackermans & van Haaren, Droia Ventures +4

How Polaris invests

Stage	Deals	Capital in rounds
Series B+	14 58%	$1B
Series A	8 33%	$586.5M
Pre-seed	2 8%	$2M

Year	Deals	Capital in rounds
2016	1 4%	$6.5M
2017	2 8%	$75M
2020	2 8%	$99M
2021	3 13%	$184M
2022	2 8%	$172M
2023	3 13%	$292M
2024	4 17%	$188M
2025	3 13%	$331M
2026	4 17%	$242M

Polaris portfolio companies

SSoufflé Therapeutics$135MSeries B+ · Oct 2026
TTropic Biosciences$105MSeries B+ · Mar 2026
KKash$2MPre-seed · Feb 2026
BBirch HillPre-seed · Feb 2026
SSovato$41MSeries B+ · Nov 2025
CCohere Health$90MSeries B+ · May 2025
VVico Therapeutics$71MSeries B+ · Jun 2024
DDelphia Therapeutics$67MSeries A · May 2024
CCrossbow Therapeutics$80MSeries A · Jul 2023
PParatus Sciences$100MSeries A · Mar 2023
NNoema Pharma$112MSeries B+ · Mar 2023
AAugust Bioservices$65MSeries B+ · Dec 2022
JJnana Therapeutics$107MSeries B+ · Nov 2022
FFloqast$110MSeries B+ · Jul 2021
TTriGemX Biobacker
ZZag Biobacker
RReadyForZerobacker
QQualaroobacker
RRecurlybacker
CCubicPVbacker

Company	Round with Polaris	Total raised	Latest raise
SSoufflé Therapeutics Health and bio	Oct 13, 2026 Series B+ · $135M	$335M	Oct 13, 2026 Series B+
TTropic Biosciences Commerce and retail	Mar 12, 2026 Series B+ · $105M	$140M	Mar 12, 2026 Series B+
KKash Prediction markets	Feb 24, 2026 Pre-seed · $2M	$2M	Feb 24, 2026 Pre-seed
BBirch Hill RWA and tokenization	Feb 11, 2026 Pre-seed	$6.5M	Oct 28, 2026 Seed
SSovato Health and bio	Nov 4, 2025 Series B+ · $41M	$41M	Nov 4, 2025 Series B+
CCohere Health Fintech	May 14, 2025 Series B+ · $90M	$150M	May 17, 2026 Series B+
VVico Therapeutics Health and bio	Jun 24, 2024 Series B+ · $71M	$71M	Jun 24, 2024 Series B+
DDelphia Therapeutics Health and bio	May 2, 2024 Series A · $67M	$67M	May 2, 2024 Series A
CCrossbow Therapeutics Health and bio	Jul 11, 2023 Series A · $80M	$157M	Mar 26, 2026 Series B+
PParatus Sciences Health and bio	Mar 8, 2023 Series A · $100M · lead	$100M	Mar 8, 2023 Series A
NNoema Pharma Health and bio	Mar 7, 2023 Series B+ · $112M	$171M	Nov 4, 2025 Series B+
AAugust Bioservices Health and bio	Dec 1, 2022 Series B+ · $65M	$89M	Dec 1, 2022 Series B+
JJnana Therapeutics Health and bio	Nov 15, 2022 Series B+ · $107M	$207M	Nov 15, 2022 Series B+
FFloqast Legal and compliance	Jul 21, 2021 Series B+ · $110M	$281.5M	Apr 10, 2024 Series B+
TTriGemX Bio Health and bio	backer	$94M	Oct 1, 2026 round
ZZag Bio Health and bio	backer	undisclosed	—
RReadyForZero Stablecoins	backer	undisclosed	—
QQualaroo Data and analytics	backer	undisclosed	—
RRecurly Fintech	backer	undisclosed	—
CCubicPV AI infrastructure and compute	backer	$103M	Jun 13, 2023 round

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Venture funds Polaris raised, from the list of new VC funds compiled by Shai Goldman (Brex). Each size links to the article that states it, or to that list where no article was found. All new funds: new VC funds.

Share is of the 24 rounds on Recent Funding that name Polaris. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Polaris, which is a subset of its real portfolio. API: /api/v1/investors/polaris (get a free API key). More: the most active VC firms and new venture capital funds.